STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
TSHA
(TSHA)
TSHA
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
Key Metrics
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$1.53B
+306.4%
P/E Ratio
-16.13
-232.9%
P/S Ratio
179.93
+246.5%
ROE
-44.14%
+64.6%
ROIC
-34.88%
+48.1%
FCF Yield
-5.34%
+71.7%
Debt/Equity
0.07
-91.7%
Current Ratio
12.23
+125.6%
Interest Coverage
-1753.94x
-95.6%
Per Share
Revenue/Share
$0.03
-8.2%
Net Income/Share
$-0.34
+4.5%
Operating CF/Share
$-0.29
+10.3%
Free CF/Share
$-0.29
+10.0%
Cash/Share
$1.00
+79.9%
Book Value/Share
$0.77
+170.1%
Tangible Book/Share
$0.77
+170.1%
Equity/Share
$0.77
+170.1%
Interest Debt/Share
$0.06
-77.5%
Valuation
Market Cap
$1.53B
+306.4%
Enterprise Value
$1.23B
+308.6%
P/E Ratio
-16.13
-232.9%
P/S Ratio
179.93
+246.5%
P/OCF Ratio
-18.89
-254.6%
P/FCF Ratio
-18.74
-253.4%
P/B Ratio
7.12
+17.7%
P/TB Ratio
7.12
+17.7%
EV/Sales
125.82
+248.4%
EV/EBITDA
-11.41
-233.4%
Profitability
Earnings Yield
-6.20%
+70.0%
FCF Yield
-5.34%
+71.7%
ROE
-44.14%
+64.6%
ROIC
-34.88%
+48.1%
Return on Tangible Assets
-31.75%
+43.0%
Capital Allocation
CapEx/OCF
-0.79%
-72.2%
CapEx/Revenue
7.55%
+68.3%
CapEx/Depreciation
0.64
+114.6%
SBC/Revenue
136.07%
-13.5%
Balance Sheet
Debt/Equity
0.07
-91.7%
Debt/Assets
0.05
-86.6%
Net Debt/EBITDA
2.80
+224.4%
Current Ratio
12.23
+125.6%
Interest Coverage
-1753.94x
-95.6%
Income Quality
0.85
-6.1%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$0.70
+248.2%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Taysha Gene Therapies, Inc.
(TSHA)
$5.96
▼
-0.34 (-5.40%)
Chart
Share
Post on X
TSHA
Taysha Gene Therapies, Inc.
(TSHA)
NASDAQ
$5.96
▼
-0.34 (-5.40%)
Chart Studio
Share
TSHA